"Avoidable Deaths" - Union for International Cancer Control
"Back to Basics: The Concept of HRQL Under a Magnifying Glass" - EORTC Quality of Life Group
"Bald for a Cause" initiative - UWC Dilijan College
Heidi Ko: Our latest mini-review on HER2 as a tumor-agnostic biomarker
Arndt Vogel: A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas
Meet Elizabeth Platz, Tuesday at 1:30 PM CT at the Publications Booth 2615 - AACR
Teresa Amaral and Evandro de Azambuja Highlighted the Importance of ESMO Research Fellowships
Caner Saygin: How TP53-mutant CH progresses during myeloma therapy
Myeloma Paper of the Day, June 5th, suggested by Robert Orlowski
